Delivery of nalbuphine and its prodrugs across skin by passive diffusion and iontophoresis

Journal of Controlled Release

Volumn 67, Issue 1, 2000, Pages 1-8

  Sung, K C ^a   Fang, Jia You ^b,c   Yoa Pu Hu, Oliver ^d  

^a CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Iontophoresis; Nalbuphine; Nalbuphine prodrug; Transdermal delivery

Indexed keywords

NALBUPHINE; NALBUPHINE DECANOATE; NALBUPHINE ENANTHATE; NALBUPHINE PIVALATE; PRODRUG; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG STABILITY; DRUG TRANSPORT; FEMALE; IN VITRO STUDY; IONTOPHORESIS; LIPOPHILICITY; MOUSE; NONHUMAN; PARTITION COEFFICIENT; PASSIVE TRANSPORT; PRIORITY JOURNAL; SKIN PERMEABILITY; STRATUM CORNEUM;

ADMINISTRATION, CUTANEOUS; ANALGESICS, OPIOID; ANIMALS; DIFFUSION; DRUG STABILITY; FEMALE; HUMANS; IONTOPHORESIS; MALE; MICE; MICE, INBRED HRS; MIDDLE AGED; NALBUPHINE; OCTANOLS; PRODRUGS; RATS; RATS, WISTAR; SKIN ABSORPTION; SOLUBILITY;

EID: 0034660379     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(99)00269-2     Document Type: Article

References (26)

1. Varghese E., Khar R.K. Enhanced skin permeation of diclofenac by iontophoresis: in vitro and in vivo studies. J. Control. Rel. 38:1996;21-27.
2. Riviere J.E., Heit M.C. Electrically assisted transdermal drug delivery. Pharm. Res. 14:1997;687-697.
3. Del Terzo S., Behl C.R., Nash R.A. Iontophoretic transport of a homologous series of ionized and unionized model compounds: influence of hydrophobicity and mechanistic interpretation. Pharm. Res. 6:1989;85-90.
4. Wearley L.L., Tojo K., Chien Y.W. A numerical approach to study the effect of binding on the iontophoretic transport of a series of amino acids. J. Pharm. Sci. 79:1990;992-998.
5. Hirvonen J., Kalia Y.N., Guy R.H. Transdermal delivery of peptides by iontophoresis. Nature Biotechnol. 14:1996;1710-1713.
6. Kontturi K., Murtomaki L. Mechanistic model for transdermal transport including iontophoresis. J. Control. Rel. 41:1996;177-185.
7. Cherny N.I. Opoid analgesics: comparative features and prescribing guidelines. Drugs. 51:1996;713-737.
8. Lo M.W., Schary W.L., Whitney C.C. Jr. The disposition and bioavailibility of intravenous and oral nalbuphine in healthy volunteers. J. Clin. Pharmacol. 27:1987;866-873.
9. J.J. Wang, Pharmacodynamic and pharmacokinetic studies with long acting novel nalbuphine prodrugs, Ph.D. Thesis, National Defense Medical Center, Taiwan, 1992.
10. Sung K.C., Han R.Y., Hu O.Y.P., Hsu L.R. Controlled release of nalbuphine prodrugs from biodegradable polymer matrices: influence of prodrug hydrophilicity and polymer composition. Int. J. Pharm. 172:1998;17-25.
11. Roy S.D., Flynn G.L. Transdermal delivery of narcotic analgesics: comparative permeabilities of narcotic analgesics through human cadaver skin. Pharm. Res. 6:1989;825-832.
12. Fang J.Y., Wu P.C., Huang Y.B., Tsai Y.H. In vitro permeation study of capsaicin and its synthetic derivatives from ointment bases using various skin types. Int. J. Pharm. 126:1995;119-128.
13. Johansen M., Mollgaard B., Wotton P.K., Larsen C., Hoelgaard A. In vitro evaluation of dermal prodrug delivery - transport and bioconversion of a series of aliphatic esters of metronidazole. Int. J. Pharm. 32:1986;199-206.
14. Pannatier A., Testa B., Etter J.C. Enzymatic hydrolysis by mouse skin homogenates: structure-metabolism relationship of p-nitrobenzoate esters. Int. J. Pharm. 8:1981;167-174.
15. Mukai E., Arase K., Hashida M., Sezaki H. Enhanced delivery of mitomicin C prodrugs through the skin. Int. J. Pharm. 25:1985;95-103.
16. Rautio J., Taipale H., Gynther J., Vespalainen J., Nevalainen T., Jarvinen T. In vitro evaluation of acyloxyalkyl esters as dermal prodrugs of ketoprofen and naproxen. J. Pharm. Sci. 87:1998;1622-1628.
17. Yoshida N.H., Roberts M.S. Solute molecular size and transdermal iontophoresis across excised human skin. J. Control. Rel. 25:1993;177-195.
18. Heit M.C., Monteiro-Riviere N.A., Jayes F.L., Reviere J.E. Transdermal iontophoretic delivery of luteinizing hormone releasing hormone (LHRH): effect of repeated administration. Pharm. Res. 11:1994;1000-1003.
19. Oldenburg K.R., Vo K.T., Smith G.A., Selick H.E. Iontophoretic delivery of oligonucleotides across full thickness hairless mouse skin. J. Pharm. Sci. 84:1995;915-921.
20. Lee A.J., King J.R., Barett D.A. Percutaneous absorption: a multiple pathway model. J. Control. Rel. 45:1997;141-151.
21. Santi P., Catellani P.L., Massimo G., Zanardi G., Colombo P. Iontophoretic transport of verapamil and melatonin I. Cellophane membrane as a barrier. Int. J. Pharm. 92:1993;23-28.
22. Fang J.Y., Lin H.H., Chen H.I., Tsai Y.H. Development and evaluation on transdermal delivery of enoxacin via chemical enhancers and physical iontophoresis. J. Control. Rel. 54:1998;293-304.
23. Luzardo-Alvarez A., Rodriguez-Fernandez M., Blanco-Mendez J., Guy R.H., Delgado-Charro M.B. Iontophoretic permselectivity of mammalian skin: characterization of hairless mouse and porcine membrane models. Pharm. Res. 15:1998;984-987.
24. Pechtold L.A.R.M., Abraham W., Potts R.O. The influence of an electric field on ion and water accessibility to stratum corneum lipid lamellae. Pharm. Res. 13:1996;1168-1173.
25. Lee R.D., White H.S., Scott E.R. Visualization of iontophoretic transport paths in cultured and animal skin models. J. Pharm. Sci. 85:1996;1186-1190.
26. Bronaugh R.L., Stewart R.F., Condon E.R. Methods for in vitro percutaneous absorption studies II: animal models for human skin. Toxicol. Appl. Pharmacol. 62:1982;481-488.